US FDA approves higher dose of Novo Nordisk's hit weight-loss drug Wegovy

The approval comes as Novo Nordisk struggles to regain market share from competitors like Eli Lilly and faces price pressures due to Trump’s cost-cutting drive for drugs

Read Full Article →